Trials / Completed
CompletedNCT06738420
Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders
Efficacy and Tolerability of a Nutritional Supplementation With Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders: a Pilot Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- AB Biotek · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy and tolerability of ABB i5 prebiotic and ABB C22 postbiotics for the management of constipation and gastrointestinal well-being: a pilot trial
Conditions
- Diarrhoea of Diverse Aetiology Requiring Oral Rehydration Therapy
- Diarrhoea and Gastrointestinal Symptoms Secondary to Enteral Nutrition
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ABB S3 | Postbiotic ABB S3 for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition |
| DIETARY_SUPPLEMENT | ABB C22 | Oral Rehydration Solution containing postbiotics ABB C22 for the management of diarrhoea signs of dehydration |
| DIETARY_SUPPLEMENT | Placebo | Placebo for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition |
| DIETARY_SUPPLEMENT | Placebo | Oral Rehydration Solution containing placebo for the management of diarrhoea signs of dehydration |
Timeline
- Start date
- 2023-01-27
- Primary completion
- 2024-03-06
- Completion
- 2024-04-04
- First posted
- 2024-12-17
- Last updated
- 2025-10-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06738420. Inclusion in this directory is not an endorsement.